EPIRUS Biopharmaceuticals, Inc. Accounts Payable
EPIRUS Biopharmaceuticals, Inc. had Accounts Payable of $3.75 million as of 2016-03-31, per its 10-Q filed 2016-05-10.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2016-05-10
- 2016-03-31: Accounts Payable, Current $3.75M.
- 2015-12-31: Accounts Payable, Current $2.05M.
- 2015-09-30: Accounts Payable, Current $2.98M.
- 2015-06-30: Accounts Payable, Current $1.86M.
| Period end | Accounts Payable, Current | Accounts Payable, Current as first filed |
|---|---|---|
| 2016-03-31 | $3.75M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $2.05M 10-Q · filed 2016-05-10 | |
| 2015-09-30 | $2.98M 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $1.86M 10-Q · filed 2015-08-12 | |
| 2015-03-31 | $2.66M 10-Q · filed 2015-05-13 | |
| 2014-12-31 | $2.48M 10-K · filed 2016-03-29 | |
| 2014-09-30 | $1.76M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $387.00K 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $1.47M 10-Q · filed 2014-05-09 | |
| 2013-12-31 | $1.07M 10-K · filed 2015-03-31 | $2.24M 10-K · filed 2014-03-14 |
| 2013-09-30 | $1.22M 10-Q · filed 2013-11-04 | |
| 2013-06-30 | $1.43M 10-Q · filed 2013-08-05 | |
| 2013-03-31 | $1.43M 10-Q · filed 2013-05-03 | |
| 2012-12-31 | $3.26M 10-K · filed 2014-03-14 | |
| 2012-09-30 | $2.19M 10-Q · filed 2012-11-08 | |
| 2012-06-30 | $1.74M 10-Q · filed 2012-08-07 | |
| 2012-03-31 | $2.69M 10-Q · filed 2012-05-04 | |
| 2011-12-31 | $1.74M 10-K · filed 2013-03-07 | |
| 2011-09-30 | $1.68M 10-Q · filed 2011-11-04 | |
| 2011-06-30 | $1.26M 10-Q · filed 2011-08-04 | |
| 2010-12-31 | $1.84M 10-K · filed 2012-03-09 |